Singapore has established itself as the leading hub for life sciences investments in the Asia Pacific region, capturing the majority of investment volume in the first nine months of 2024. According to a JLL report, Singapore's government has played a significant role in promoting the development of this sector. Key transactions during this period include the Brunei Investment Agency acquiring a 49% stake in Ho Bee Land's Elementum for US$206 million, and a joint venture between Warburg Pincus and Lendlease purchasing a US$1.2 billion portfolio from Blackstone and the Lim family, consisting of business parks and specialist facilities geared toward life sciences, technology, advanced manufacturing, and logistics. JLL highlighted Singapore's global leadership in innovation and talent, making it a prime location for multinational life sciences firms. However, the report also noted a shortage of high-quality life sciences and R&D spaces, suggesting opportunities for investors to convert industrial assets into specialized labs or engage in sale and leaseback deals.
James 101542649 :